Phibro Animal Health (NASDAQ:PAHC) Reaches New 1-Year High on Analyst Upgrade

Phibro Animal Health Co. (NASDAQ:PAHC)’s stock price reached a new 52-week high during mid-day trading on Tuesday after Barclays raised their price target on the stock from $20.00 to $22.00. Barclays currently has an underweight rating on the stock. Phibro Animal Health traded as high as $26.42 and last traded at $26.22, with a volume of 874178 shares traded. The stock had previously closed at $23.69.

PAHC has been the subject of several other research reports. StockNews.com cut Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research note on Thursday, February 6th. Morgan Stanley raised their target price on Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a research note on Tuesday, December 17th. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $21.00.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. Quantbot Technologies LP acquired a new position in Phibro Animal Health in the 3rd quarter worth about $70,000. nVerses Capital LLC acquired a new position in Phibro Animal Health in the 3rd quarter worth about $70,000. China Universal Asset Management Co. Ltd. increased its position in Phibro Animal Health by 63.7% in the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock worth $88,000 after purchasing an additional 1,522 shares during the last quarter. New York State Teachers Retirement System increased its position in Phibro Animal Health by 16.7% in the 4th quarter. New York State Teachers Retirement System now owns 5,428 shares of the company’s stock worth $114,000 after purchasing an additional 775 shares during the last quarter. Finally, CWM LLC increased its holdings in shares of Phibro Animal Health by 190.8% during the 3rd quarter. CWM LLC now owns 6,363 shares of the company’s stock valued at $143,000 after acquiring an additional 4,175 shares during the last quarter. 99.34% of the stock is owned by institutional investors and hedge funds.

Phibro Animal Health Stock Performance

The company has a current ratio of 3.20, a quick ratio of 1.69 and a debt-to-equity ratio of 2.99. The firm has a market cap of $1.06 billion, a price-to-earnings ratio of 54.63, a price-to-earnings-growth ratio of 0.53 and a beta of 0.52. The stock has a fifty day moving average price of $21.90 and a 200 day moving average price of $21.70.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $0.54 EPS for the quarter, beating analysts’ consensus estimates of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. As a group, analysts predict that Phibro Animal Health Co. will post 1.94 earnings per share for the current year.

Phibro Animal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th will be issued a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 1.83%. The ex-dividend date is Wednesday, March 5th. Phibro Animal Health’s dividend payout ratio (DPR) is currently 100.00%.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.